Convergent Therapeutics and IONETIX announce supply agreement for therapeutic radioisotope actinium-225 (Ac-225)
Convergent Therapeutics Inc., a clinical stage radiopharmaceutical company, and IONETIX Corporation, a leading cyclotron technology, and isotope manufacturing company, today announced a long-term supply agreement for the therapeutic medical radioisotope, ...
Read more
